Back to Results
First PageMeta Content
Condoms / Antiseptics / Microbicides / Microbicides for sexually transmitted diseases / LifeStyles Condoms / Female condom / Ansell / Australian Securities Exchange / Dendrimer / Chemistry / Medicine / Biology


VivaGel® condom approved for sale with launch imminent Melbourne, Australia; 2 October 2014: Starpharma (ASX:SPL, OTCQX:SPHRY) today announced the inclusion of the VivaGel® condom in the Australian Register of Therapeu
Add to Reading List

Document Date: 2014-10-06 22:45:28

Open Document

File Size: 114,51 KB

Share Result on Facebook

City

Melbourne / /

Company

Melbourne Australia / Ansell Limited / Starpharma Pty Ltd. / Lilly / Woolworths / AstraZeneca / Okamoto Industries / Starpharma Holdings Limited / /

Country

Japan / Australia / /

/

Event

FDA Phase / Business Partnership / /

IndustryTerm

retail outlets / positive social media commentary / social media / retail shelves / marketed product / dendrimer products / media coverage / pharmaceutical and medical uses / /

MarketIndex

ASX 300 / /

MedicalCondition

important cancer / bacterial vaginosis / tumour / /

MedicalTreatment

dendrimer / dendrimers / /

Organization

FDA / /

Person

Adama / Jackie Fairley / Chris Kalaitzis / Rebecca Wilson Mob / Gabriella Hold / /

/

Position

general public pricing pressures / Chief Executive Officer / CFO and Company Secretary / market leader / VP of Sales and Marketing for Asia Pacific / leader in the development / leader / /

Product

VivaGel / Taxotere / VivaGel® / /

Region

Asia Pacific / /

Technology

drug delivery / /

URL

http /

SocialTag